FTSE 100 May Defy Pharma, Oil Sector Pressures as Defensive Plays Attract Flows

Published 16/05/2025, 08:16

While much of the tariff damage has been repaired, the reprieve could prove temporary, with investors under no illusions that the end game is yet in sight.

Even after the short-term tariff truce between the US and China, levels are higher than prior to the election, and it is unclear whether the announced measures are filtering through to the real economies just yet. Recession fears have receded for the time being, but rising production costs and supply chain blockages will have an impact.

The stronger-than-expected growth in the most recent UK GDP figures was a relief yesterday, although there is a strong likelihood that the figure was front-loaded with the pain yet to be fully felt.

The rises in employment taxes only came into effect in April, while the effects of the tariffs are likely to have global implications, which will put pressure on trade. Even so, the economy has shown resilience, which has surprised most economists, and the domestically focused FTSE 250 has erased earlier losses to currently stand up by 1.1% in the year to date.

Despite having to deal with some recent pressure on the pharmaceutical sector given the US President Donald Trump’s latest comments on lowering drug prices, and an crude oil price which has fallen by 13.5% so far this year inevitably impacting the majors, the premier index has continued to defy gravity amid the global turmoil.

Another defiant opening was propelled by some buying of the pharmas, while there was also a smattering of interest among the defensive stocks as investors hedged their bets. The FTSE 100 has now added 6.1% in the year so far, with an average dividend yield of 3.5% adding to the ongoing attraction of the index as an investment destination on a total return basis.

Meanwhile, the vitally important US consumer is also showing some signs of strain. Retail sales increased by just 0.1% last month, with Walmart (NYSE:WMT) being the latest to add to the recent chorus of needing to raise its prices imminently, while also backing away from profit guidance for the upcoming quarter.

There was slightly better news from an unexpected decline in wholesale prices last month, where a dip of 0.5% compared to estimates of a 0.3% increase, implying that the inflation genie remains in the bottle for now.

Indeed, investors have been quick to ride the temporary rise in sentiment, and the mega-cap technology stocks have staged a rebound as the hunt for growth stocks resumes.

A strong week for the likes of Nvidia (NASDAQ:NVDA) and Tesla (NASDAQ:TSLA), both of which have risen by around 15%, reduces their year to date losses to 2% and 9% respectively, while there has also been some notable bargain hunting among the rest of the “Magnificent Seven”, with both Meta Platforms and Microsoft (NASDAQ:MSFT) easing into positive territory.

Potential technology deals with Saudi Arabia have also boosted sentiment, and after some sharp earlier declines, the Nasdaq is now down by just 1% so far this year, the Dow Jones by 0.5%, while the benchmark S&P 500 is marginally ahead with a 0.6% increase reflecting the improved mood.

Asian markets were mixed overnight, and investors remain skittish given the potential for a breakdown in tariff talk negotiations. Closer to home, the Nikkei drifted lower as the Japanese economy contracted at a faster rate than expected in the first quarter, driven by flat consumer spending and a fall in exports. In Hong Kong, meanwhile, the main index was weighed down by an update from Alibaba (NYSE:BABA) which missed estimates, sending its shares some 5% lower.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.